{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:30:57Z","timestamp":1789525857756,"version":"build-2803163510"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mam.2026.101478","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:49:22Z","timestamp":1778604562000},"page":"101478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Integrating immunopeptidomics with liquid biopsy for precision oncology"],"prefix":"10.1016","volume":"110","author":[{"given":"Doryan","family":"Masmoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6401-2903","authenticated-orcid":false,"given":"Catherine","family":"Alix-Panabi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Eslami-S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2026.101478_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0005-2736(99)00171-6","article-title":"Function of the transport complex TAP in cellular immune recognition","volume":"1461","author":"Abele","year":"1999","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.mam.2026.101478_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fimmu.2015.00335","article-title":"Intracellular transport routes for MHC I and their relevance for antigen cross-presentation","volume":"6","author":"Adiko","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib3","unstructured":"Admon, A. in Seminars in Immunology. 101766 (Elsevier)."},{"key":"10.1016\/j.mam.2026.101478_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/cancers11040483","article-title":"Heterogeneity in circulating tumor cells: the relevance of the stem-cell subset","volume":"11","author":"Agnoletto","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2026.101478_bib5","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/db24-0827","article-title":"Soluble HLA class I is released from human \u03b2-cells following exposure to interferons","volume":"74","author":"Akhbari","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.mam.2026.101478_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.jbchem.a124327","article-title":"Interferon-\u03b3 induces different subunit organizations and functional diversity of proteasomes","volume":"115","author":"Aki","year":"1994","journal-title":"J. Biochem."},{"key":"10.1016\/j.mam.2026.101478_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1373\/clinchem.2012.194258","article-title":"Circulating tumor cells: liquid biopsy of cancer","volume":"59","author":"Alix-Panabi\u00e8res","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mam.2026.101478_bib8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/2159-8290.CD-20-1311","article-title":"Liquid biopsy: from discovery to clinical application","volume":"11","author":"Alix-Panabi\u00e8res","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mam.2026.101478_bib9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/2159-8290.CD-20-1311","article-title":"Liquid biopsy: from discovery to clinical application","volume":"11","author":"Alix-Panabi\u00e8res","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mam.2026.101478_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccell.2024.11.009","article-title":"Advances in liquid biopsy: from exploration to practical application","volume":"43","author":"Alix-Panabi\u00e8res","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mam.2026.101478_bib11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: history, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2026.101478_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nri842","article-title":"Selection and fine-tuning of the autoimmune T-cell repertoire","volume":"2","author":"Anderton","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102878","article-title":"Interferon-\u03b3 induces immunoproteasomes and the presentation of MHC I-associated peptides on human salivary gland cells","volume":"9","author":"Arellano-Garcia","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2026.101478_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40364-023-00540-2","article-title":"Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology","volume":"11","author":"Asleh","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.mam.2026.101478_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1540431","article-title":"Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response","volume":"16","author":"Balakrishnan","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41698-025-00876-y","article-title":"Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology","volume":"9","author":"Bartolomucci","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.mam.2026.101478_bib17","series-title":"Proceedings of the National Academy of Sciences","first-page":"18769","article-title":"Soluble plasma HLA peptidome as a potential source for cancer biomarkers","volume":"107","author":"Bassani-Sternberg","year":"2010"},{"key":"10.1016\/j.mam.2026.101478_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13404","article-title":"Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry","volume":"7","author":"Bassani-Sternberg","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2026.101478_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13404","article-title":"Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry","volume":"7","author":"Bassani-Sternberg","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2026.101478_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005725","article-title":"Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity","volume":"13","author":"Bassani-Sternberg","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.mam.2026.101478_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12859-018-2561-z","article-title":"Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome","volume":"20","author":"Boehm","year":"2019","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.mam.2026.101478_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40364-024-00680-z","article-title":"Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: unveiling resistance mechanisms with the CoDuCo in situ assay","volume":"12","author":"Bonstingl","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.mam.2026.101478_bib23","doi-asserted-by":"crossref","first-page":"13236","DOI":"10.1074\/jbc.M112.442640","article-title":"Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters","volume":"288","author":"Bosch","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mam.2026.101478_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413554","article-title":"What is the role of HLA-I on cancer derived extracellular vesicles? Defining the challenges in characterisation and potential uses of this ligandome","volume":"22","author":"Boyne","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2026.101478_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.146","article-title":"Characterising the HLA-I immunopeptidome of plasma-derived extracellular vesicles in patients with melanoma","volume":"3","author":"Boyne","year":"2024","journal-title":"J. Extracell. Bio."},{"key":"10.1016\/j.mam.2026.101478_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.146","article-title":"Characterising the HLA\u2010I immunopeptidome of plasma\u2010derived extracellular vesicles in patients with melanoma","volume":"3","author":"Boyne","year":"2024","journal-title":"J. Extracell. Bio."},{"key":"10.1016\/j.mam.2026.101478_bib27","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202110798","article-title":"Ultra\u2010high sensitivity mass spectrometry quantifies single\u2010cell proteome changes upon perturbation","volume":"18","author":"Brunner","year":"2022","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.mam.2026.101478_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nbt.4313","article-title":"Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification","volume":"37","author":"Bulik-Sullivan","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mam.2026.101478_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adv6445","article-title":"Immunopeptidomics-guided discovery and characterization of neoantigens for personalized cancer immunotherapy","volume":"11","author":"Cai","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mam.2026.101478_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/1521-4141(200103)31:3<841::AID-IMMU841>3.0.CO;2-D","article-title":"The transmembrane segment of invariant chain mediates binding to MHC class II molecules in a CLIP\u2010independent manner","volume":"31","author":"Castellino","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib31","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1158\/0008-5472.CAN-14-2613","article-title":"Establishment and characterization of a cell line from human circulating colon cancer cells","volume":"75","author":"Cayrefourcq","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.mam.2026.101478_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.immuni.2024.12.004","article-title":"Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation","volume":"58","author":"Champagne","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2026.101478_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng0696-210","article-title":"A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer","volume":"13","author":"Chen","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mam.2026.101478_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.38249","article-title":"Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA\u2013B27","volume":"66","author":"Chen","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.mam.2026.101478_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.21147\/j.issn.1000-9604.2021.03.10","article-title":"Single-cell DNA methylome analysis of circulating tumor cells","volume":"33","author":"Chen","year":"2021","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.mam.2026.101478_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41541-025-01234-6","article-title":"Proteogenomic approach to immunopeptidomics of ovarian tumors identifies shared peptide vaccine candidates","volume":"10","author":"Chiaro","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.mam.2026.101478_bib37","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41467-020-14968-9","article-title":"Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes","volume":"11","author":"Chong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2026.101478_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41587-021-01038-8","article-title":"Identification of tumor antigens with immunopeptidomics","volume":"40","author":"Chong","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mam.2026.101478_bib39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1039\/D0SC03636F","article-title":"Ultrasensitive single-cell proteomics workflow identifies> 1000 protein groups per mammalian cell","volume":"12","author":"Cong","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.mam.2026.101478_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","article-title":"Liquid biopsies: the future of cancer early detection","volume":"21","author":"Connal","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.mam.2026.101478_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.critrevonc.2018.12.004","article-title":"The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): international expert consensus paper","volume":"134","author":"Cristofanilli","year":"2019","journal-title":"Crit. Rev. Oncol.-Hematol."},{"key":"10.1016\/j.mam.2026.101478_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/2326-6066.CIR-24-0320","article-title":"Alternate MHC I antigen presentation pathways allow CD8+ T-cell recognition and killing of cancer cells in the absence of \u03b22M or TAP","volume":"13","author":"Cruz","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mam.2026.101478_bib43","article-title":"Most non-canonical proteins uniquely populate the proteome or immunopeptidome","volume":"34","author":"Cuevas","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.mam.2026.101478_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151624","article-title":"A TCR mimic monoclonal antibody reactive with the \u201cpublic\u201d phospho-neoantigen pIRS2\/HLA-A\u2217 02: 01 complex","volume":"7","author":"Dao","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.mam.2026.101478_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90061-6","article-title":"HLA-DM induces CLIP dissociation from MHC class II \u03b1\u03b2 dimers and facilitates peptide loading","volume":"82","author":"Denzin","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.mam.2026.101478_bib46","article-title":"CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer","volume":"32","author":"Duan","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.mam.2026.101478_bib47","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/2326-6066.CIR-19-0886","article-title":"Identification of the cryptic HLA-I immunopeptidome","volume":"8","author":"Erhard","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mam.2026.101478_bib48","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3389\/fonc.2020.01055","article-title":"The metastatic Cascade as the basis for liquid biopsy development","volume":"10","author":"Eslami","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mam.2026.101478_bib49","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037333","article-title":"The different facets of liquid biopsy: a kaleidoscopic view","volume":"10","author":"Eslami","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.mam.2026.101478_bib50","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41416-022-01819-1","article-title":"Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade","volume":"127","author":"Eslami-S","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mam.2026.101478_bib51","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.5505","article-title":"Immunopeptidomics workflow for isolation and LC-MS\/MS analysis of MHC class I-Bound peptides under hypoxic conditions","volume":"15","author":"Estephan","year":"2025","journal-title":"Bio-protocol"},{"key":"10.1016\/j.mam.2026.101478_bib52","unstructured":"Feola, S., Chiaro, J. & Cerullo, V. in Seminars in Immunology. 101750 (Elsevier)."},{"key":"10.1016\/j.mam.2026.101478_bib53","doi-asserted-by":"crossref","first-page":"15992","DOI":"10.1021\/acsnano.1c04371","article-title":"PeptiCHIP: a microfluidic platform for tumor antigen landscape identification","volume":"15","author":"Feola","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.mam.2026.101478_bib54","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.71156","article-title":"A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines","volume":"11","author":"Feola","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.mam.2026.101478_bib55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-397863-9.00003-1","article-title":"Immunoproteasomes: structure, function, and antigen presentation","volume":"109","author":"Ferrington","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.mam.2026.101478_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-\u03b3 pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.mam.2026.101478_bib57","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3389\/fimmu.2019.01392","article-title":"Determinants for neoantigen identification","volume":"10","author":"Garcia-Garijo","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib58","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41592-019-0426-7","article-title":"Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning","volume":"16","author":"Gessulat","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mam.2026.101478_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645770","article-title":"IFN\u03b3 modulates the immunopeptidome of triple negative breast cancer cells by enhancing and diversifying antigen processing and presentation","volume":"12","author":"Goncalves","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib60","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1373\/clinchem.2016.260299","article-title":"Accession of tumor heterogeneity by multiplex transcriptome profiling of single circulating tumor cells","volume":"62","author":"Gorges","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mam.2026.101478_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38079-9","article-title":"Plasma proteome of growing tumors","volume":"13","author":"Gupta","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2026.101478_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190333","article-title":"Dysregulation in IFN-\u03b3 signaling and response: the barricade to tumor immunotherapy","volume":"14","author":"Han","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib63","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ab.2015.03.003","article-title":"Evaluating the effects of preanalytical variables on the stability of the human plasma proteome","volume":"478","author":"Hassis","year":"2015","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.mam.2026.101478_bib64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13045-019-0788-4","article-title":"TCR-like antibodies in cancer immunotherapy","volume":"12","author":"He","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mam.2026.101478_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13045-019-0812-8","article-title":"Targeting cancers through TCR-peptide\/MHC interactions","volume":"12","author":"He","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mam.2026.101478_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187323","article-title":"Downregulation of TAP1 and TAP2 in early stage breast cancer","volume":"12","author":"Henle","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2026.101478_bib67","article-title":"A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy","volume":"1\u201313","author":"Huber","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mam.2026.101478_bib68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1039\/C3LC50582K","article-title":"Advances and critical concerns with the microfluidic enrichments of circulating tumor cells","volume":"14","author":"Hyun","year":"2014","journal-title":"Lab Chip"},{"key":"10.1016\/j.mam.2026.101478_bib69","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/cancers13102290","article-title":"Longitudinal evaluation of PD-L1 expression on circulating tumor cells in non-small cell lung cancer patients treated with nivolumab","volume":"13","author":"Ikeda","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2026.101478_bib70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00418-023-02258-6","article-title":"From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy","volume":"161","author":"Imodoye","year":"2024","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.mam.2026.101478_bib71","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10549-017-4452-9","article-title":"Molecular characterization and heterogeneity of circulating tumor cells in breast cancer","volume":"166","author":"Jakabova","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mam.2026.101478_bib72","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1021\/acs.analchem.4c02347","article-title":"Nanobody-based microfluidic immunosensor chip using tetraphenylethylene-derived covalent organic frameworks as aggregation-induced electrochemiluminescence emitters for the detection of thymic stromal lymphopoietin","volume":"96","author":"Jia","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.mam.2026.101478_bib73","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.6330","article-title":"A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mam.2026.101478_bib74","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s12951-024-02858-x","article-title":"Multiparametric profiling of HER2-enriched extracellular vesicles in breast cancer using single extracellular VEsicle Nanoscopy","volume":"22","author":"Jiang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mam.2026.101478_bib75","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.4049\/jimmunol.1301043","article-title":"ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides","volume":"191","author":"Kanaseki","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-3083.2002.01053.x","article-title":"MHC class I molecules and the missing self","volume":"55","author":"K\u00e4rre","year":"2002","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib77","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/vaccines8040775","article-title":"The potential of soluble human leukocyte antigen molecules for early cancer detection and therapeutic vaccine design","volume":"8","author":"Kessler","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.mam.2026.101478_bib78","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo6135","article-title":"Quantitative immunopeptidomics reveals a tumor stroma\u2013specific target for T cell therapy","volume":"14","author":"Kim","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mam.2026.101478_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.tig.2024.09.003","article-title":"The cryptic immunopeptidome in health and disease","author":"Kina","year":"2025","journal-title":"Trends Genet."},{"key":"10.1016\/j.mam.2026.101478_bib80","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3390\/ijms24010769","article-title":"Blood plasma proteome: a meta-analysis of the results of protein quantification in human blood by targeted mass spectrometry","volume":"24","author":"Kliuchnikova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2026.101478_bib81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41416-018-0186-7","article-title":"Detection of circulating tumour cell clusters in human glioblastoma","volume":"119","author":"Krol","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mam.2026.101478_bib82","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/imm.13471","article-title":"Tumour\u2010associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles","volume":"166","author":"Kumar","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.mam.2026.101478_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19336918.2024.2395807","article-title":"Liquid biopsy: paving a new avenue for cancer research","volume":"18","author":"Kurma","year":"2024","journal-title":"Cell Adhes. Migrat."},{"key":"10.1016\/j.mam.2026.101478_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110529","article-title":"Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion","volume":"27","author":"Lapuente-Santana","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.mam.2026.101478_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10238","article-title":"Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames","volume":"7","author":"Laumont","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2026.101478_bib86","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5516","article-title":"Noncoding regions are the main source of targetable tumor-specific antigens","volume":"10","author":"Laumont","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mam.2026.101478_bib87","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12943-025-02426-3","article-title":"Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment","volume":"24","author":"Le","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mam.2026.101478_bib88","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1365-2567.2001.01250.x","article-title":"The contributions of T-cell anergy to peripheral T-cell tolerance","volume":"103","author":"Lechler","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.mam.2026.101478_bib89","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccell.2020.07.013","article-title":"Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors","volume":"38","author":"Leko","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mam.2026.101478_bib90","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.3390\/cancers14204968","article-title":"Mining the immunopeptidome for antigenic peptides in cancer","volume":"14","author":"Le\u00f3n-Letelier","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2026.101478_bib91","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s43018-023-00600-4","article-title":"CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D\u2013NKG2DL axis","volume":"4","author":"Lerner","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mam.2026.101478_bib92","article-title":"A microfluidics-enabled automated workflow of sample preparation for MS-based immunopeptidomics","volume":"3","author":"Li","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.mam.2026.101478_bib93","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1356143","article-title":"TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer","volume":"6","author":"Ling","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.mam.2026.101478_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2015.00001","article-title":"Macropinocytosis in phagocytes: regulation of MHC class-II-restricted antigen presentation in dendritic cells","volume":"6","author":"Liu","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.mam.2026.101478_bib95","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.immuni.2012.09.011","article-title":"T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens","volume":"38","author":"Mandl","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2026.101478_bib96","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/tra.12026","article-title":"Presentation of phagocytosed antigens by MHC class I and II","volume":"14","author":"Mantegazza","year":"2013","journal-title":"Traffic"},{"key":"10.1016\/j.mam.2026.101478_bib97","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003404","article-title":"Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors","volume":"9","author":"Marcu","year":"2021","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.mam.2026.101478_bib98","first-page":"67","article-title":"High-throughput, fast, and sensitive immunopeptidomics sample processing for mass spectrometry","author":"Marino","year":"1913","journal-title":"Methods in molecular biology (Clifton, N.J."},{"key":"10.1016\/j.mam.2026.101478_bib99","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1038\/s41467-024-47062-5","article-title":"The physiological interactome of TCR-like antibody therapeutics in human tissues","volume":"15","author":"Marrer-Berger","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2026.101478_bib100","article-title":"Whole-exome tumor-agnostic ctDNA analysis enhances minimal residual disease detection and reveals relapse mechanisms in localized colon cancer","volume":"1\u201317","author":"Mart\u00edn-Arana","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mam.2026.101478_bib101","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/cancers11111659","article-title":"Circulating tumor cells in pancreatic cancer: current perspectives","volume":"11","author":"Martini","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2026.101478_bib102","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/1878-0261.13665","article-title":"Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells","volume":"19","author":"Masmoudi","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.mam.2026.101478_bib103","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/1878-0261.13665","article-title":"Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells","volume":"19","author":"Masmoudi","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.mam.2026.101478_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41563-018-0091-8","article-title":"Cancer immunotherapy making headway","volume":"17","author":"Matsiko","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.mam.2026.101478_bib105","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3390\/biology12121514","article-title":"Immunopeptidomics in the era of single-cell proteomics","volume":"12","author":"Mayer","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.mam.2026.101478_bib106","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.mam.2026.101478_bib107","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00262-007-0362-8","article-title":"Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma","volume":"57","author":"Mehta","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.mam.2026.101478_bib108","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/367837","article-title":"Molecular backgrounds of ERAP1 downregulation in cervical carcinoma","volume":"2015","author":"Mehta","year":"2015","journal-title":"Anal. Cell. Pathol."},{"key":"10.1016\/j.mam.2026.101478_bib109","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/bib\/bbz051","article-title":"A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction","volume":"21","author":"Mei","year":"2020","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.mam.2026.101478_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40132-6","article-title":"Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer","volume":"13","author":"Mej\u00eda-Guarnizo","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2026.101478_bib111","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature18003","article-title":"Proteogenomics connects somatic mutations to signalling in breast cancer","volume":"534","author":"Mertins","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.mam.2026.101478_bib112","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-4-16","article-title":"Saliva soluble HLA as a potential marker of response to interferon-\u03b21a in multiple sclerosis: a preliminary study","volume":"4","author":"Minagar","year":"2007","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.mam.2026.101478_bib113","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/cas.16118","article-title":"Emerging potential of immunopeptidomics by mass spectrometry in cancer immunotherapy","volume":"115","author":"Minegishi","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.mam.2026.101478_bib114","series-title":"Proceedings of the National Academy of Sciences","first-page":"14292","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010"},{"key":"10.1016\/j.mam.2026.101478_bib115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41587-019-0392-8","article-title":"Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas","volume":"38","author":"Moncada","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mam.2026.101478_bib116","first-page":"157","article-title":"Increased circulating levels of soluble HLA class I heterodimers in patients with sickle cell disease","volume":"90","author":"Moore","year":"1998","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.mam.2026.101478_bib117","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1039\/D3AN00080J","article-title":"Optimizing single cell proteomics using trapped ion mobility spectrometry for label-free experiments","volume":"148","author":"Mun","year":"2023","journal-title":"Analyst"},{"key":"10.1016\/j.mam.2026.101478_bib118","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.mam.2026.101478_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105643","article-title":"Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity","volume":"25","author":"Nelde","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.mam.2026.101478_bib120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s40425-019-0769-8","article-title":"Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment","volume":"7","author":"Newey","year":"2019","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.mam.2026.101478_bib121","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1158\/2767-9764.CRC-23-0121","article-title":"Multifactorial remodeling of the cancer immunopeptidome by IFN\u03b3","volume":"3","author":"Newey","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.mam.2026.101478_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2025.100964","article-title":"ERAP1 activity modulates the Immunopeptidome but also affects the proteome, metabolism, and stress responses in cancer cells","volume":"24","author":"Nikopaschou","year":"2025","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2026.101478_bib123","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cels.2020.06.010","article-title":"MHCflurry 2.0: improved pan-allele prediction of MHC class I-Presented peptides by incorporating antigen processing","volume":"11","author":"O'Donnell","year":"2020","journal-title":"Cell Syst."},{"key":"10.1016\/j.mam.2026.101478_bib124","first-page":"4043","article-title":"Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients","volume":"9","author":"Ogino","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mam.2026.101478_bib125","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1158\/1078-0432.CCR-10-3019","article-title":"Baseline circulating tumor cell counts significantly enhance a prognostic score for patients participating in phase I oncology trials","volume":"17","author":"Olmos","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mam.2026.101478_bib126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.mam.2026.101478_bib127","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/cancers12030737","article-title":"Recognition dynamics of cancer mutations on the ERp57-tapasin interface","volume":"12","author":"Padariya","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2026.101478_bib128","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1016\/j.csbj.2021.09.006","article-title":"Structural determinants of peptide-dependent TAP1-TAP2 transit passage targeted by viral proteins and altered by cancer-associated mutations","volume":"19","author":"Padariya","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.mam.2026.101478_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100080","article-title":"Sensitive immunopeptidomics by leveraging available large-scale Multi-HLA spectral libraries, data-independent acquisition, and MS\/MS prediction","volume":"20","author":"Pak","year":"2021","journal-title":"Mol. Cell. Proteomics : MCP"},{"key":"10.1016\/j.mam.2026.101478_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100080","article-title":"Sensitive immunopeptidomics by leveraging available large-scale multi-HLA spectral libraries, data-independent acquisition, and MS\/MS prediction","volume":"20","author":"Pak","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2026.101478_bib131","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s40364-023-00534-0","article-title":"Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges","volume":"11","author":"Pang","year":"2023","journal-title":"Biomarker Res."},{"key":"10.1016\/j.mam.2026.101478_bib132","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.molmed.2010.07.001","article-title":"Circulating tumour cells in cancer patients: challenges and perspectives","volume":"16","author":"Pantel","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mam.2026.101478_bib133","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1373\/clinchem.2015.242537","article-title":"Functional studies on viable circulating tumor cells","volume":"62","author":"Pantel","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mam.2026.101478_bib134","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41571-019-0187-3","article-title":"Liquid biopsy and minimal residual disease \u2014 latest advances and implications for cure","volume":"16","author":"Pantel","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mam.2026.101478_bib135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbrc.2003.11.153","article-title":"Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis","volume":"313","author":"Park","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mam.2026.101478_bib136","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.3390\/cancers13143408","article-title":"Therapeutic cancer vaccination with immunopeptidomics-discovered antigens confers protective antitumor efficacy","volume":"13","author":"Peltonen","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2026.101478_bib137","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1158\/0008-5472.CAN-11-0568","article-title":"Tumor microenvironment\u2013derived proteins dominate the plasma proteome response during breast cancer induction and progression","volume":"71","author":"Pitteri","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.mam.2026.101478_bib138","doi-asserted-by":"crossref","first-page":"801","DOI":"10.37349\/etat.2024.00249","article-title":"Immunopeptidomics in the cancer immunotherapy era","volume":"5","author":"Pongcharoen","year":"2024","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.mam.2026.101478_bib139","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.mam.2026.101478_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100111","article-title":"Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentation","volume":"20","author":"Pyke","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2026.101478_bib141","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/pmic.200400942","article-title":"Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry","volume":"5","author":"Qian","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.mam.2026.101478_bib142","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/mi15060706","article-title":"Novel isolating approaches to circulating tumor cell enrichment based on microfluidics: a review","volume":"15","author":"Qiao","year":"2024","journal-title":"Micromachines"},{"key":"10.1016\/j.mam.2026.101478_bib143","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju066","article-title":"Circulating tumor cells predict survival in early average-to-high risk breast cancer patients","volume":"106","author":"Rack","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mam.2026.101478_bib144","series-title":"HLA Typing: Methods and Protocols","first-page":"215","author":"Racle","year":"2024"},{"key":"10.1016\/j.mam.2026.101478_bib145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads7405","article-title":"Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer","volume":"11","author":"Raja","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mam.2026.101478_bib146","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf314","article-title":"Deciphering the MHC immunopeptidome of human cancers with Ligand. MHC atlas","volume":"26","author":"Ran","year":"2025","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.mam.2026.101478_bib147","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/imm.12675","article-title":"Antigen processing and immune regulation in the response to tumours","volume":"150","author":"Reeves","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.mam.2026.101478_bib148","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mam.2026.101478_bib149","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.mam.2026.101478_bib150","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/360474a0","article-title":"HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides","volume":"360","author":"Riberdy","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.mam.2026.101478_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201600364","article-title":"Purification of soluble HLA class I complexes from human serum or plasma deliver high quality immuno peptidomes required for biomarker discovery","volume":"17","author":"Ritz","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.mam.2026.101478_bib152","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","article-title":"The ins and outs of MHC class II-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib153","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13073-023-01275-3","article-title":"Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer","volume":"16","author":"Rospo","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.mam.2026.101478_bib154","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1074\/mcp.RA118.000610","article-title":"Comparative proteomics of dying and surviving cancer cells improves the identification of drug targets and sheds light on cell life\/death decisions","volume":"17","author":"Saei","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2026.101478_bib155","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.mam.2026.101478_bib156","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.mam.2026.101478_bib157","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.mam.2026.101478_bib158","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.humimm.2010.02.015","article-title":"Prognostic relevance of soluble human leukocyte antigen\u2013G and total human leukocyte antigen class I molecules in lung cancer patients","volume":"71","author":"Sch\u00fctt","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib159","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005651","article-title":"T cells of colorectal cancer patients' stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells","volume":"10","author":"Schwarz","year":"2022","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.mam.2026.101478_bib160","first-page":"361","article-title":"Different regulation of MHC class I antigen processing components in human tumors","volume":"5","author":"Seliger","year":"2008","journal-title":"J. Immunot."},{"key":"10.1016\/j.mam.2026.101478_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100515","article-title":"Benchmarking bioinformatics pipelines in data-independent acquisition mass spectrometry for immunopeptidomics","volume":"22","author":"Shahbazy","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2026.101478_bib162","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mam.2026.101478_bib163","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1074\/mcp.RA119.001524","article-title":"Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma","volume":"18","author":"Shraibman","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2026.101478_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-374279-7.14009-3","article-title":"Activation of CD8 T lymphocytes during viral infections","volume":"286","author":"Sigal","year":"2016","journal-title":"Encyclopedia of immunobiology"},{"key":"10.1016\/j.mam.2026.101478_bib165","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/clinchem\/hvab131","article-title":"Programmed cell death ligand 1-expressing circulating tumor cells: a new prognostic biomarker in non-small cell lung cancer","volume":"67","author":"Sinoquet","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mam.2026.101478_bib166","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/375802a0","article-title":"Mediation by HLA-DM of dissociation of peptides from HLA-DR","volume":"375","author":"Sloan","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.mam.2026.101478_bib167","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1084\/jem.186.7.1087","article-title":"Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing","volume":"186","author":"Snyder","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mam.2026.101478_bib168","first-page":"998","article-title":"Comparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypes","volume":"6","author":"Stoehr","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.mam.2026.101478_bib169","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fonc.2014.00363","article-title":"A role for naturally occurring alleles of endoplasmic reticulum aminopeptidases in tumor immunity and cancer pre-disposition","volume":"4","author":"Stratikos","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mam.2026.101478_bib170","article-title":"Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery","volume":"3","author":"Stutzmann","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.mam.2026.101478_bib171","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15440","article-title":"Acquired IFN\u03b3 resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions","volume":"8","author":"Sucker","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2026.101478_bib172","doi-asserted-by":"crossref","first-page":"17084","DOI":"10.1074\/jbc.M117.805895","article-title":"The major histocompatibility complex class I immunopeptidome of extracellular vesicles","volume":"292","author":"Synowsky","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mam.2026.101478_bib173","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00109-021-02088-w","article-title":"Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer","volume":"99","author":"Tabassum","year":"2021","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.mam.2026.101478_bib174","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.leukres.2006.06.008","article-title":"Soluble HLA revisited","volume":"31","author":"Tabayoyong","year":"2007","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mam.2026.101478_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1069635","article-title":"Soluble HLA peptidome: a new resource for cancer biomarkers","volume":"12","author":"Tanuwidjaya","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mam.2026.101478_bib176","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.celrep.2019.12.079","article-title":"Quantitative and dynamic catalogs of proteins released during apoptotic and necroptotic cell death","volume":"30","author":"Tanzer","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.mam.2026.101478_bib177","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016873","article-title":"MHC class II antigen presentation by dendritic cells regulated through endosomal sorting","volume":"5","author":"Ten Broeke","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.mam.2026.101478_bib178","first-page":"1","article-title":"The global challenge of cancer","volume":"1","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mam.2026.101478_bib179","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10555-025-10293-z","article-title":"Single-cell RNA-sequencing of circulating tumour cells: a practical guide to workflow and translational applications","volume":"44","author":"Tieng","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.mam.2026.101478_bib180","first-page":"424","article-title":"Therapeutic potential of cancer vaccine based on MHC class I cryptic peptides derived from non-coding regions","volume":"1","author":"Tokita","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.mam.2026.101478_bib181","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado6491","article-title":"Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes","volume":"10","author":"Tokita","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mam.2026.101478_bib182","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0952-7915(99)80034-X","article-title":"Specificity of the proteasome and the TAP transporter","volume":"11","author":"Uebel","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib183","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.4049\/jimmunol.0902414","article-title":"TCR mimic monoclonal antibody targets a specific peptide\/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models","volume":"184","author":"Verma","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1219720","article-title":"Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics","volume":"14","author":"Wacker","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2026.101478_bib185","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12885-023-10785-7","article-title":"Down-regulation of ERAP1 mRNA expression in non-small cell lung cancer","volume":"23","author":"Wagner","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mam.2026.101478_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100689","article-title":"IMBAS-MS discovers organ-specific HLA peptide patterns in plasma","volume":"23","author":"Wahle","year":"2024","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2026.101478_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115675","article-title":"Challenges and opportunities on achieving an adequate delivery efficiency and immunogenicity with peptide-based anticancer vaccines","volume":"225","author":"Wang","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mam.2026.101478_bib188","first-page":"56","article-title":"Advancements in mass spectrometry-based proteomics: a new era in pathology research and diagnostics","volume":"45","author":"Werner","year":"2024","journal-title":"Pathologie (Heidelberg, Germany)"},{"key":"10.1016\/j.mam.2026.101478_bib189","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13058-025-02056-z","article-title":"Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients","volume":"27","author":"Wilhelm","year":"2025","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mam.2026.101478_bib190","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41467-020-14290-4","article-title":"Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-\u03b3-signaling mutant cancer cells","volume":"11","author":"Williams","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2026.101478_bib191","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mam.2026.101478_bib192","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mam.2026.101478_bib193","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.xphs.2023.03.017","article-title":"Pharmacokinetic approach for the elucidation of elevated plasma small extracellular vesicle (sEV) concentration in cancer","volume":"112","author":"Yamamoto","year":"2023","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.mam.2026.101478_bib194","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41587-022-01567-w","article-title":"Facile repurposing of peptide\u2013MHC-restricted antibodies for cancer immunotherapy","volume":"41","author":"Yang","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mam.2026.101478_bib195","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1186\/s12967-024-05908-y","article-title":"Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis","volume":"22","author":"Yazdi","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.mam.2026.101478_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100230","article-title":"MHC class I immunopeptidome: past, present, and future","volume":"21","author":"Yewdell","year":"2022","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2026.101478_bib197","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70887-5","article-title":"Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence","volume":"14","author":"Yoo","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2026.101478_bib198","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.molcel.2021.01.010","article-title":"Interferon-\u03b3 induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation","volume":"81","author":"Yu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mam.2026.101478_bib199","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1438111","article-title":"Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy","volume":"7","author":"Yue","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.mam.2026.101478_bib200","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.mam.2026.101478_bib201","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2026.101478_bib202","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.1158\/0008-5472.CAN-14-0043","article-title":"MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer","volume":"74","author":"Zarling","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.mam.2026.101478_bib203","doi-asserted-by":"crossref","first-page":"10160","DOI":"10.1074\/jbc.M808356200","article-title":"ERp57 does not require interactions with calnexin and calreticulin to promote assembly of class I histocompatibility molecules, and it enhances peptide loading independently of its redox activity","volume":"284","author":"Zhang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mam.2026.101478_bib204","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature13438","article-title":"Proteogenomic characterization of human colon and rectal cancer","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mam.2026.101478_bib205","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1158\/2326-6066.CIR-18-0940","article-title":"Systemic interferon-\u03b3 increases MHC class I expression and T-cell infiltration in cold tumors: results of a phase 0 clinical trial","volume":"7","author":"Zhang","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mam.2026.101478_bib206","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.3390\/cancers15235639","article-title":"Small antibodies with big applications: nanobody-based cancer diagnostics and therapeutics","volume":"15","author":"Zhang","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2026.101478_bib207","article-title":"Advances and challenges in neoantigen prediction for cancer immunotherapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299726000348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299726000348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:23:28Z","timestamp":1783603408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299726000348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":207,"alternative-id":["S0098299726000348"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2026.101478","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating immunopeptidomics with liquid biopsy for precision oncology","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2026.101478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101478"}}